Skip to main content
NCBI home page
Mediators of Inflammation logoLink to Mediators of Inflammation
. 1998;7(4):295–297. doi: 10.1080/09629359890992

Circulating Th1 and Th2 cytokines in patients with hepatitis C virus infection.

X G Fan 1, W E Liu 1, C Z Li 1, Z C Wang 1, L X Luo 1, D M Tan 1, G L Hu 1, Z Zhang 1
PMCID: PMC1781851  PMID: 9792341

Abstract

The imbalance of T-helper (Th) lymphocyte cytokine production may play an important role in immunopathogenesis of persistent hepatitis C virus (HCV) infection. To know whether an imbalance between Th1 and Th2 cytokines is present in chronic HCV infection, serum levels of Th1 cytokines, interferon gamma (IFN-gamma) and interleukin (IL)-2, and Th2 cytokines, IL-4 and IL-10, were measured using enzyme-linked immunosorbent assay in this study. Eighteen individuals with chronic HCV infection, 11 healthy subjects as normal controls and 10 chronic HBV infected patients as disease controls were observed. The results showed that the levels of Th2 cytokines (IL-4 and IL-10) were significantly increased in chronic HCV infected patients compared with normal controls (IL-4: 30.49+/-17.55 vs. 14.94+/-13.73, pg/ml, P<0.025; IL-10: 50.30+/-19.59 vs. 17.87+/-9.49, pg/ml, P<0.001). Similarly, the levels of Th1 cytokine, IL-2, was also elevated in individuals with chronic HCV infection when compared with normal controls (IL-2: 118.53+/-95.23 vs. 61.57+/-28.70, pg/ml, P<0.05). However, Th1 cytokine IFN-gamma level was not significantly changed during HCV infection (IFN-gamma: 28.09+/-15.65 vs. 24.10+/-15.61, pg/ml, P>0.05). Furthermore, the elevated levels of Th2 cytokines are greater than Th1 cytokines in HCV infection. Thus, the study indicates that an enhanced Th2 responses are present during chronic HCV infection, which may partly be responsible for the persistence of HCV infection.

Full Text

The Full Text of this article is available as a PDF (127.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Bertoletti A., D'Elios M. M., Boni C., De Carli M., Zignego A. L., Durazzo M., Missale G., Penna A., Fiaccadori F., Del Prete G. Different cytokine profiles of intraphepatic T cells in chronic hepatitis B and hepatitis C virus infections. Gastroenterology. 1997 Jan;112(1):193–199. doi: 10.1016/s0016-5085(97)70235-x. [DOI] [PubMed] [Google Scholar]
  2. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987 Apr;162(1):156–159. doi: 10.1006/abio.1987.9999. [DOI] [PubMed] [Google Scholar]
  3. Clerici M., Shearer G. M. A TH1-->TH2 switch is a critical step in the etiology of HIV infection. Immunol Today. 1993 Mar;14(3):107–111. doi: 10.1016/0167-5699(93)90208-3. [DOI] [PubMed] [Google Scholar]
  4. Fan X. G., Yakoob J., Fan X. J., Keeling P. W. Effect of IL-4 on peripheral blood lymphocyte proliferation: implication in immunopathogenesis of H. pylori infection. Immunol Lett. 1995 Nov;48(1):45–48. doi: 10.1016/0165-2478(95)02440-9. [DOI] [PubMed] [Google Scholar]
  5. Fan X. G., Yakoob J., Fan X. J., Keeling P. W. Enhanced T-helper 2 lymphocyte responses: immune mechanism of Helicobacter pylori infection. Ir J Med Sci. 1996 Jan-Mar;165(1):37–39. doi: 10.1007/BF02942800. [DOI] [PubMed] [Google Scholar]
  6. Fan X., Zhang Z. Increased tumour necrosis factor alpha production by neutrophils in patients with hepatitis B. J Clin Pathol. 1994 Jul;47(7):616–618. doi: 10.1136/jcp.47.7.616. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Hoffmann R. M., Diepolder H. M., Zachoval R., Zwiebel F. M., Jung M. C., Scholz S., Nitschko H., Riethmüller G., Pape G. R. Mapping of immunodominant CD4+ T lymphocyte epitopes of hepatitis C virus antigens and their relevance during the course of chronic infection. Hepatology. 1995 Mar;21(3):632–638. [PubMed] [Google Scholar]
  8. Iwata K., Wakita T., Okumura A., Yoshioka K., Takayanagi M., Wands J. R., Kakumu S. Interferon gamma production by peripheral blood lymphocytes to hepatitis C virus core protein in chronic hepatitis C infection. Hepatology. 1995 Oct;22(4 Pt 1):1057–1064. doi: 10.1016/0270-9139(95)90609-6. [DOI] [PubMed] [Google Scholar]
  9. Kiyosawa K., Sodeyama T., Tanaka E., Gibo Y., Yoshizawa K., Nakano Y., Furuta S., Akahane Y., Nishioka K., Purcell R. H. Interrelationship of blood transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology. 1990 Oct;12(4 Pt 1):671–675. doi: 10.1002/hep.1840120409. [DOI] [PubMed] [Google Scholar]
  10. Modlin R. L., Nutman T. B. Type 2 cytokines and negative immune regulation in human infections. Curr Opin Immunol. 1993 Aug;5(4):511–517. doi: 10.1016/0952-7915(93)90031-m. [DOI] [PubMed] [Google Scholar]
  11. Tsai S. L., Liaw Y. F., Yeh C. T., Chu C. M., Kuo G. C. Cellular immune responses in patients with dual infection of hepatitis B and C viruses: dominant role of hepatitis C virus. Hepatology. 1995 Apr;21(4):908–912. [PubMed] [Google Scholar]
  12. Weiner A. J., Geysen H. M., Christopherson C., Hall J. E., Mason T. J., Saracco G., Bonino F., Crawford K., Marion C. D., Crawford K. A. Evidence for immune selection of hepatitis C virus (HCV) putative envelope glycoprotein variants: potential role in chronic HCV infections. Proc Natl Acad Sci U S A. 1992 Apr 15;89(8):3468–3472. doi: 10.1073/pnas.89.8.3468. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Mediators of Inflammation are provided here courtesy of Wiley

RESOURCES